Digoxin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Digoxin and local guidelines before prescribing.

Cardiac glycoside

Mechanism

Inhibits Na-K ATPase, increasing intracellular calcium and vagal tone.

Uses

AF rate control, heart failure with AF symptoms.

Dosing

4 more dose entries from the chapters

Side effects

Nausea, visual disturbance (yellow-green), confusion, arrhythmias, gynaecomastia; hypokalaemia increases toxicity.

Interactions

Amiodarone, verapamil, clarithromycin raise levels; diuretics cause hypokalaemia; calcium IV caution.

Contraindications and cautions

Heart block, WPW, ventricular arrhythmia, hypertrophic cardiomyopathy

Monitoring

Level, U&E, ECG

Pregnancy and breastfeeding

Used if needed

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Digoxin-specific antibody fragments

Special advice

Narrow therapeutic index; check level 6 hours post-dose if toxicity suspected; reduce dose in renal impairment and older people; antibody fragments for severe toxicity.

More from the textbook: uses, cautions and other points
Where it is discussed in the book